Israel Englander Igm Biosciences, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 20,200 shares of IGMS stock, worth $131,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,200

Previous 391,213 94.84%

Holding current value

$131,502

Previous $2.69 Million 87.57%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $1.63 Million - $4.58 Million	-258,871 Reduced 66.17%	132,342 $2.19 Million
Q2 2024 Aug 14, 2024	SELL	$6.51 - $11.47 $1.98 Million - $3.49 Million	-303,848 Reduced 43.72%	391,213 $2.69 Million
Q1 2024 May 15, 2024	BUY	$8.68 - $17.36 $3.89 Million - $7.77 Million	447,865 Added 181.18%	695,061 $6.71 Million
Q4 2023 Feb 14, 2024	SELL	$3.94 - $8.79 $2.91 Million - $6.48 Million	-737,467 Reduced 74.9%	247,196 $2.05 Million
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $8.22 Million - $13 Million	927,203 Added 1613.65%	984,663 $9.09 Million
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $3.8 Million - $7.13 Million	-276,725 Reduced 82.81%	57,460 $790,000
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $663,886 - $1.12 Million	42,970 Added 14.76%	334,185 $5.68 Million
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $4.6 Million - $8.05 Million	-298,186 Reduced 50.59%	291,215 $6.62 Million
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $4.88 Million - $9.39 Million	368,089 Added 166.32%	589,401 $10.6 Million
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $772,428 - $1.71 Million	57,558 Added 35.15%	221,312 $5.92 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $4.09 Million - $9.84 Million	148,240 Added 955.52%	163,754 $4.8 Million
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $441,709 - $608,896	-6,717 Reduced 30.21%	15,514 $1.02 Million
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $1.04 Million - $2.03 Million	-24,214 Reduced 52.13%	22,231 $1.64 Million
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $1.91 Million - $2.8 Million	37,283 Added 406.93%	46,445 $3.39 Million
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $288,694 - $675,697	9,162 New	9,162 $514,000
Q4 2019 Feb 14, 2020	SELL	$17.25 - $49.51 $4.38 Million - $12.6 Million	-253,790 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $4.5 Million - $6.17 Million	253,790 New	253,790 $4.5 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account